The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.
A patient who, despite risk factors or comorbidities, can get on a treadmill faces low mortality risk. But the reverse is ...
This month: smelling skills predict stroke risk, insights from LGBTQ+ clinicians, BP screening in public spaces, and more.
The multisociety collaboration moves the focus from procedures to a continuum of care from diagnosis to any treatment ...
Finding the cause of angina in patients without obstructed coronaries can reassure patients and lead to tailored therapy.
Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.
A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.
Merging interventional and AHFTC training programs would be a boon for patients and the HF subspecialty, experts argue.
Demystifying the AED, and training a generation of kids in their use, is key to prevent “catastrophic” sudden deaths in young ...
The instructions for use have been updated to address issues that led to a greater risk of neurovascular events in an early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results